Small cap wrap: Medicus Pharma, Tiziana Life Sciences, Namibia Critical Metals... Proactive Investors (US) 20:32 Fri, 31 Jul
Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix Proactive Investors (US) 14:25 Fri, 31 Jul
Small cap wrap: Nextsource Materials, First Phosphate, Medicus Pharma, Nextech3D.ai… Proactive Investors (US) 20:33 Mon, 27 Jul
Medicus Pharma receives FDA clearance to begin registrational SkinJect study for Gorlin syndrome Proactive Investors (US) 14:38 Mon, 27 Jul
Market movers: AtaiBeckley, UnitedHealth Group, Abbott Laboratories, Medicus Pharma… Proactive Investors (Canada) 19:36 Thu, 16 Jul
Medicus Pharma Receives Positive FDA Feedback For Optimized Phase 2 Study Of Teverelix In Aur RTT News 14:36 Thu, 16 Jul
Medicus Pharma advances Teverelix Phase 2 study after FDA feedback, IRB approval Proactive Investors (US) 13:47 Thu, 16 Jul
